Lorena Di Lisio

785 citations
11 papers · 548 indexed · h-index 10
Topics
Cancer-related molecular mechanisms research (6 papers)MicroRNA in disease regulation (6 papers)Circular RNAs in diseases (3 papers)

In The Last Decade

Lorena Di Lisio

11 papers receiving 543 citations

Peers

Lorena Di Lisio
Comparison fields: 5 of 51
  • Molecular Biology 412
  • Cancer Research 336
  • Oncology 100
  • Pathology and Forensic Medicine 86
  • Immunology 71
Replace Aina Pons with:
Aina Pons Spain
Kazuaki Teshima Japan
Maria Cardenas United States
Hossein Pashaiefar Iran
Saeed Eshtad Sweden
Vishnupriya Satti India
Vikram R. Paralkar United States
Bo‐Wei Han China
Anna Wojtuszkiewicz Netherlands
Xuewei Zhuang China
Lorena Di Lisio relative to Aina Pons Spain Aina Pons's profile →
Citations per field
00.5×1.5×2.5×
Aina Pons · 1×
Citations per year

Countries citing papers authored by Lorena Di Lisio

Since Specialization
Citations

This map shows the geographic impact of Lorena Di Lisio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena Di Lisio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena Di Lisio more than expected).

Fields of papers citing papers by Lorena Di Lisio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena Di Lisio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena Di Lisio. The network helps show where Lorena Di Lisio may publish in the future.

Co-authorship network of co-authors of Lorena Di Lisio

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena Di Lisio. A scholar is included among the top collaborators of Lorena Di Lisio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena Di Lisio. Lorena Di Lisio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 5
2 101
3 21
4 49
5 25
6 58
7 82
8 60
9 53
10 55
11 39

About Lorena Di Lisio

Lorena Di Lisio is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 11 papers that have together received 548 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (336 citations), Molecular Biology (412 citations) and Hematology (65 citations). Lorena Di Lisio has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Miguel Á. Piris, Nerea Martı́nez, Margarita Sánchez‐Beato, Santiago Montes‐Moreno, Gonzalo Goméz-López, David G. Pisano, María E. Rodríguez, Manuela Mollejo, Miguel Ángel Martínez Martínez and Miguel Piris‐Villaespesa. Their work appears in journals such as Nucleic Acids Research, Blood and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026